ArticlePolymers2025
Molecular Engineering of Carboxylated Polysulfone Membranes for Enhancing Salt Rejection.
Article in Polymers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Polysulfone Membranes: Here, There and Everywhere.Membranes · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Developing advanced polysulfone (PSF) membranes for water treatment has garnered significant attention. However, carboxylated polysulfone membranes have shown limited rejection of various ions. This study explores four novel methods for modifying carboxylated polysulfone membranes to enhance their performance: (a) crosslinking of the dicarboxylated membrane surface with polyethylenimine or ethylenediamine, (b) partial hydrolysis of ethylenediamine-crosslinked dicarboxylated membranes to create tailored pores and surface brushes with terminal amine groups, (c) attachment of alkyl brushes to the dicarboxylated membrane surface, and (d) formation of quaternary ammonium moieties at the membrane surface. All modified membranes were fully characterized, and their enhanced functionality was confirmed. For instance, the PSF-PEI membrane exhibited a 28% CaCl
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.